Abstract
In 1878, Friedrich Engels famously wrote that on the road to realizing the communist utopia, “the state is not abolished, it withers away.” In a similar manner, biomedical researchers telling us that come the promised land of individualized genomic medicine, the need for using race will also “wither away” in the face of scientific progress. Such millennial hopes are, no doubt, sincere, but they enable the continued casual proliferation of racial categories throughout biomedical research, product development, marketing, and clinical practice. My contrasting quotation to frame this article is drawn from the 20th century pioneer of rock and roll, Buddy Holly (né Charles Hardin Holley) whose 1957 hit “Not Fade Away” begins with the line, “I’m gonna tell you how it's gonna be” — the point being that far from withering away, race is persisting even as genomic milestones are being reached and passed.
Publisher
Cambridge University Press (CUP)
Subject
Health Policy,General Medicine,Issues, ethics and legal aspects
Reference81 articles.
1. 21. Id.
2. 46. See, e.g., id.
3. 55. Ray, T. , “Competition Heats Up in Warfarin Dx Market as New Tests Seek FDA OK,” Pharmacogenomics Reporter, October 10, 2007, available at (last visited November 30, 2012).
4. 53. See, generally, Hilts, P. , Protecting America's Health: The FDA, Business, and One Hundred Years of Regulation (2003).
5. A Regulatory Science Perspective on Warfarin Therapy: A Pharmacogenetic Opportunity
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献